The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| USPH | +9.8% | +17.79% | +3.33% | +4,511% |
| S&P | +15.06% | +95.03% | +14.29% | +1,516% |
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services. The physical therapy operations segment consist of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. U.S. The company was founded in 1990 and is headquartered in Houston, TX.
Check out these companies utilizing non-pharmaceutical means to optimize America's health.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $197.34M | 18.0% |
| Gross Profit | $37.63M | 21.1% |
| Gross Margin | 19.07% | 0.5% |
| Market Cap | $1.19B | -14.7% |
| Market Cap / Employee | $0.17M | 0.0% |
| Employees | 7K | 4.6% |
| Net Income | $18.95M | 59.6% |
| EBITDA | $30.59M | 26.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $34.09M | -69.8% |
| Accounts Receivable | $65.96M | 20.7% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $256.19M | 19.7% |
| Short Term Debt | $49.21M | 9.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.14% | 1.6% |
| Return On Invested Capital | 5.38% | -1.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $31.96M | 19.2% |
| Operating Free Cash Flow | $35.22M | 20.8% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 90.53 | 48.19 | 33.29 | 34.21 | -60.93% |
| Price to Book | 2.63 | 2.77 | 2.23 | 2.39 | -17.69% |
| Price to Sales | 1.98 | 1.99 | 1.57 | 1.63 | -26.60% |
| Price to Tangible Book Value | -6.78 | -6.82 | -3.05 | -3.35 | -58.75% |
| Price to Free Cash Flow TTM | 26.53 | 33.22 | 36.02 | 33.83 | 2.90% |
| Enterprise Value to EBITDA | 83.69 | 82.26 | 75.89 | 56.37 | -21.13% |
| Free Cash Flow Yield | 3.8% | 3.0% | 2.8% | 3.0% | -2.82% |
| Return on Equity | 2.9% | 5.7% | 6.7% | 7.0% | 115.18% |
| Total Debt | $254.35M | $295.23M | $307.31M | $305.40M | 17.93% |
USPH earnings call for the period ending September 30, 2021.
USPH earnings call for the period ending June 30, 2021.
USPH earnings call for the period ending March 31, 2021.
USPH earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
